> Nutramax® Laboratories, Inc.
> Cosamin by Nutramax (Consumer Health)
> Avoca ASU 120 Count Vegetarian Joint Health Supplement
Avoca ASU 120 Count Vegetarian Joint Health Supplement
|Product Code :
|Product Price :
|Quantity in Basket:
| Product Rating
|| Be the first to
Write an online review
Manufacturer: Nutramax Laboratories, Inc
Note: Ingredients listed are based on the most current information available. Please refer to actual product packaging as formulations may change. If you have questions regarding a product or its ingredients, please contact us for more information.
- Vegetarian formula / Shellfish free
- Contains non-shellfish glucosamine , NMX1000® Avocado/Soybean
Unsaponifiables, MSM, and decaffeinated green tea
- ASU (Avocado/Soybean Unsaponifiables) is
derived from avocados and soybeans and has been shown in laboratory research
to inhibit components that result in cartilage breakdown.
- Contains decaffeinated green tea for antioxidant health benefits.
What is Avoca ASU®?
Avoca ASU is a vegetarian/shellfish-free joint health supplement that
contains non-shellfish glucosamine, NMX1000®** avocado/soybean
unsaponifiables (ASU), and methylsulfonylmethane (MSM). Avoca ASU also contains
decaffeinated green tea for antioxidant health benefits. All ingredients are
from non-animal origin.
What role do the glucosamine and ASU in Avoca ASU play?
The glucosamine in Avoca ASU enhances the production of cartilage matrix
components that keep cartilage cells healthy and functioning properly. ASU
stands for avocado/soybean unsaponifiables, derived from avocados and soybeans
and used for joint health. Studies using cartilage cells have shown that ASU
lowers the expression of several compounds involved in the process of cartilage
breakdown in the joints. ASU complements the positive effects of the glucosamine
in Avoca ASU. A greater than additive effect, known as a “synergistic” effect,
on cartilage cells was seen using ASU and glucosamine together. Avoca ASU® also
contains decaffeinated green tea for antioxidant health benefit effects.
U.S. Patent No. 6,797,289